Early Access — free while we kick the tires
EdgarHawk

Xia Yu

Director

Director
1 filing analyzed · 1 company · Latest 2025-10-23

Companies

Company Buys Sells Direction
Summit Therapeutics Inc. SMMT 1 0 Net buying

Activity

October 2025
high
Buy
533,617 shares
$9,999,983
Significance 8/10

Director Xia Yu buys 533,617 shares of SMMT at $18.74 ($10.0M) amid cluster pattern; stock down 48.9% from high

Xia Yu, a Director, purchased 533,617 shares at $18.74 on 2025-10-21, adding $10.0M in capital to a position that now stands at 32,057,147 shares. The purchase occurred as SMMT trades 48.9% below its 52-week high of $36.70 and 90-day momentum has declined 34.6%. The stock is currently unprofitable with net income of $-231,793,000 and zero quarterly revenue, signaling the company remains in an early or struggling stage. Notably, 2 other insiders also bought within the past 14 days, creating a cluster buy pattern that warrants investor attention as multiple leadership figures are deploying capital at these depressed valuations simultaneously.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access